Clinical pharmacology and therapeutics in South Korea: 30 years with the Korean Society of Clinical Pharmacology and Therapeutics

Citations

WEB OF SCIENCE

1
Citations

SCOPUS

1

초록

The Korean Society of Clinical Pharmacology and Therapeutics (KSCPT) celebrated its 33rd anniversary in 2024. In 1992, the KSCPT was founded against the backdrop of increasing global focus on drug development. Since its establishment, the society has played a leading role in advancing clinical pharmacology in Korea, promoting personalized therapy, and supporting the development of clinical trial and regulatory systems for drug development. As the field now transitions from its growth phases into a period of maturity, we take this opportunity to reflect on the history of clinical pharmacology in Korea and explore its future role and development in an evolving landscape.

키워드

PEPTIDASE-IV INHIBITOR; RECEPTOR-GAMMA AGONIST; DOUBLE-BLIND; OPEN-LABEL; PHARMACOKINETIC PROPERTIES; RENAL IMPAIRMENT; MALE-VOLUNTEERS; PHASE-I; HEALTHY; TOLERABILITY
제목
Clinical pharmacology and therapeutics in South Korea: 30 years with the Korean Society of Clinical Pharmacology and Therapeutics
저자
Kim, Tae-Eun; Yoon, Young-Ran
DOI
10.12793/tcp.2024.32.e12
발행일
2024-09
유형
Editorial Material
저널명
Translational and Clinical Pharmacology
권
32
호
3
페이지
115 ~ 126